Anti-angiogenic peptides application in cancer therapy; a review

Cancer is a disease advanced via surplus angiogenesis. The development of new anti-angiogenic therapeutic agents with more efficacy and fewer side effects is still quite necessary. Conventional therapies saving the life of many cancer patients but due to drug resistance and lack of specificity utili...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoari, Alireza, Khodabakhsh, Farnaz, Ahangari Cohan, Reza, Salimian, Morteza, Karami, Elmira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562409/
https://www.ncbi.nlm.nih.gov/pubmed/34760005
http://dx.doi.org/10.4103/1735-5362.327503

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562409/
https://www.ncbi.nlm.nih.gov/pubmed/34760005
http://dx.doi.org/10.4103/1735-5362.327503

Ejemplares similares